Literature DB >> 34590274

Identification of Synthetic Lethal Interactions Using High-Throughput, Arrayed CRISPR/Cas9-Based Platforms.

MacKenzie J MacAuley1, Omar Abuhussein2, Frederick S Vizeacoumar3,4.   

Abstract

Over the past two decades, the concept of synthetic lethality (SL) that queries genetic relationships between gene pairs has gradually emerged as one of the best strategies to selectively eliminate cancer cells. Some of the most successful approaches to identify synthetic lethal interactions (SLIs) were largely dependent on pooled screening formats that require heavy validation in order to mitigate false positives. Here, we describe a high-throughput method to identify SLIs using CRISPR-based strategy that covers, high-throughput production of plasmid DNA preparations, lentiviral production, and subsequent cellular transduction using single guide RNAs (sgRNAs). This method could be adopted to query hundreds of SLIs. As an example, we describe the methods associated with building an interaction map for DNA damage and repair (DDR) genes. The use of multiwell plates and image-based quantification allows a comparative measurement of SLIs at a high-resolution on a one-by-one basis. Furthermore, this scalable, arrayed CRISPR screening method can be applied to multiple cancer cell types, and genes of interest, resulting in new functional discoveries that can be exploited therapeutically.
© 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRISPR/Cas9; Genetic knockout; Genomic editing; High-throughput; Synthetic lethal interaction; Synthetic lethality; sgRNA

Mesh:

Substances:

Year:  2021        PMID: 34590274     DOI: 10.1007/978-1-0716-1740-3_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Homologous recombination in DNA repair and DNA damage tolerance.

Authors:  Xuan Li; Wolf-Dietrich Heyer
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

2.  Defining a Cancer Dependency Map.

Authors:  Aviad Tsherniak; Francisca Vazquez; Phil G Montgomery; Barbara A Weir; Gregory Kryukov; Glenn S Cowley; Stanley Gill; William F Harrington; Sasha Pantel; John M Krill-Burger; Robin M Meyers; Levi Ali; Amy Goodale; Yenarae Lee; Guozhi Jiang; Jessica Hsiao; William F J Gerath; Sara Howell; Erin Merkel; Mahmoud Ghandi; Levi A Garraway; David E Root; Todd R Golub; Jesse S Boehm; William C Hahn
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

3.  DNA double strand break repair via non-homologous end-joining.

Authors:  Anthony J Davis; David J Chen
Journal:  Transl Cancer Res       Date:  2013-06       Impact factor: 1.241

Review 4.  A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality.

Authors:  Sreejit Parameswaran; Deeksha Kundapur; Frederick S Vizeacoumar; Andrew Freywald; Maruti Uppalapati; Franco J Vizeacoumar
Journal:  Trends Cancer       Date:  2018-12-07

Review 5.  Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.

Authors:  Sarah R Hengel; M Ashley Spies; Maria Spies
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

6.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

Review 7.  Exploring genetic interactions and networks with yeast.

Authors:  Charles Boone; Howard Bussey; Brenda J Andrews
Journal:  Nat Rev Genet       Date:  2007-06       Impact factor: 53.242

Review 8.  Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.

Authors:  John Paul Shen; Trey Ideker
Journal:  J Mol Biol       Date:  2018-06-20       Impact factor: 5.469

9.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

Authors:  John G Doench; Nicolo Fusi; Meagan Sullender; Mudra Hegde; Emma W Vaimberg; Jennifer Listgarten; Katherine F Donovan; Ian Smith; Zuzana Tothova; Craig Wilen; Robert Orchard; Herbert W Virgin; David E Root
Journal:  Nat Biotechnol       Date:  2016-01-18       Impact factor: 54.908

10.  Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.

Authors:  Kyuho Han; Edwin E Jeng; Gaelen T Hess; David W Morgens; Amy Li; Michael C Bassik
Journal:  Nat Biotechnol       Date:  2017-03-20       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.